Role of the ACM
The ACM provides independent medical and scientific advice to the Minister for Health and the Therapeutic Goods Administration (TGA) on issues relating to the safety, quality and efficacy of medicines supplied in Australia including issues relating to pre-market and post-market functions for medicines.
The Committee is established under Regulation 35 of the Therapeutic Goods Regulations 1990. Members are appointed by the Minister.
The ACM was established in January 2017, to encompass pre and post-market advice for medicines, following the consolidation of the previous functions of the Advisory Committee on Prescription Medicines (ACPM), the Advisory Committee on the Safety of Medicines (ACSOM) and the Advisory Committee on Non-Prescription Medicines (ACNM).
Membership comprises of professionals with specific scientific, medical or clinical expertise, as well as appropriate consumer health issues relating to medicines.
Membership
The current membership of the committee can be found on our ACM members page.
2022 ACM proposed meeting dates
| Meeting no. | Meeting dates |
|---|---|
| 31 | 3-4 Feb 2022 |
| 32 | 1 April 2022 |
| 33 | 2-3 June 2022 |
| 34 | 4-5 August 2022 |
| 35 | 6-7 October 2022 |
| 36 | 1-2 December 2022 |
Contact details for the ACM
| Medicines enquiries | Committee support enquiries | |
|---|---|---|
| acm@health.gov.au | Committees@health.gov.au | |
| Phone | +61 2 6289 2915 or +61 418 205 547 |
|
| Postal Address | Advisory Committee on Medicines Therapeutic Goods Administration PO Box 100 WODEN ACT 2606 Attn: Prescription Medicines Authorisation Branch, MDP 122 |
Committee Support Unit Therapeutic Goods Administration PO Box 100 WODEN ACT 2606 Attn: Scheduling & Committee Support Section, MDP 122 |
Outcomes
- Meeting statementsACM meeting statement, Meeting 34, 4-5 August 2022Advisory Committee on Medicines meeting statement
- Meeting statementsACM meeting statement, Meeting 35, 6-7 October 2022Advisory Committee on Medicines meeting statement
- Meeting statementsACM meeting statement, Meeting 32, 1 April 2022Advisory Committee on Medicines meeting statement, Meeting 32, 1 April 2022